Pharmaceutical - Mergers & Acquisitions, Sanofi

Filter

Popular Filters

Briefs: Merz Pharma pulls out of Obagi bid; Aubagio approved in Argentina

08-04-2013

German family-owned Merz Pharma says that it has withdrawn its non-binding proposal to acquire all of…

AubagioBiotechnologyGenzymeMergers & AcquisitionsMerz PharmaceuticalsObagi Medical ProductsPharmaceuticalRegulationSanofiSouth AmericaValeant Pharmaceuticals

Sanofi sells US drug rights to Covis; Prices bond issue

08-04-2013

Privately held Swiss specialty drug firm Covis Pharma has reached agreement with a USA-based unit of…

Covis PharmaFinancialMergers & AcquisitionsNorth AmericaPharmaceuticalSanofi

Briefs: Sanofi to up stake in Regeneron; Bayer files for riociguat approval

12-02-2013

US biotech Regeneron Pharmaceuticals (Nasdaq: REGN) saw its shares rise 4.8% to $173.84 in early trading…

BayerBiotechnologyEuropeFinancialMergers & AcquisitionsNorth AmericaPharmaceuticalRegeneronRegulationRespiratory and PulmonaryriociguatSanofi

News briefs from Sanofi, Bayer, GlaxoSmithKline and Novartis

21-12-2012

French drug major Sanofi (Euronext: SAN) has entered into a binding agreement to acquire the animal health…

BayerDosch PharmaceuticalsExjadeFlonaseGlaxoSmithKlineLegalMergers & AcquisitionsMerialNovartisOncologyPharmaceuticalregorafenibRegulationRespiratory and PulmonarySanofi

Analyst insight: Sanofi eyes Columbia, Indonesia and Vietnam

20-09-2012

Emerging markets, BRIC countries are words that have recently risen to prominence in a majority of pharmaceutical…

Asia-PacificLicensingMarkets & MarketingMergers & AcquisitionsPharmaceuticalSanofiSouth America

News briefs from Merck KGaA and Sanofi

05-07-2012

German drug major Merck KGaA )MRK: DE) revealed this morning that its Phase III EXPAND trial, which assessed…

cilengitideErbituxManagementMerck KGaAMergers & AcquisitionsPharmaceuticalResearchSanofi

Sanofi's Aubagio reduces MS relapse; firm aims to build diabetes portfolio

01-06-2012

Genzyme, a subsidiary of French drug major Sanofi (Euronext: SAN) today reported top-line results from…

AubagioBiotechnologyDiabetesGenzymeMergers & AcquisitionsNeurologicalPharmaceuticalResearchSanofiteriflunomide

Amylin said to be attracting several Big Pharma suitors

16-05-2012

US biotech firm Amylin Pharmaceuticals (Nasdaq: AMLN), which earlier this year rebuffed a $22 per share…

AmylinAstraZenecaBiotechnologyBristol-Myers SquibbMerck & CoMergers & AcquisitionsPfizerPharmaceuticalRocheSanofiTakeda Pharmaceuticals

Sanofi expands in biosurgery, buying Pluromed

18-03-2012

French drug major Sanofi (Euronext: SAN) said on Friday that it is to acquire Pluromed, a USA-based medical…

Mergers & AcquisitionsPharmaceuticalPluromedSanofi

Back to top